Matches in Wikidata for { <http://www.wikidata.org/entity/Q79103069> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q79103069 description "article scientifique publié en 2003" @default.
- Q79103069 description "artículu científicu espublizáu n'ochobre de 2003" @default.
- Q79103069 description "im Oktober 2003 veröffentlichter wissenschaftlicher Artikel" @default.
- Q79103069 description "scientific article published on 01 October 2003" @default.
- Q79103069 description "wetenschappelijk artikel" @default.
- Q79103069 description "наукова стаття, опублікована в жовтні 2003" @default.
- Q79103069 description "مقالة علمية تنشرت ف 1 أكتوبر 2003" @default.
- Q79103069 name "Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group" @default.
- Q79103069 name "Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group" @default.
- Q79103069 type Item @default.
- Q79103069 label "Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group" @default.
- Q79103069 label "Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group" @default.
- Q79103069 prefLabel "Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group" @default.
- Q79103069 prefLabel "Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group" @default.
- Q79103069 P1433 Q79103069-9CF3F5F1-85AB-4CFF-993F-1CEEE3598179 @default.
- Q79103069 P1476 Q79103069-11C6F060-EDC7-46AD-8732-FBFCCA72286F @default.
- Q79103069 P2093 Q79103069-57D03401-5A41-46C5-8BB4-0C0581BA6840 @default.
- Q79103069 P2093 Q79103069-592313C8-029A-4474-9A05-203D3FF8F0E8 @default.
- Q79103069 P2093 Q79103069-6D502FD1-148A-4FF0-98CF-BA348263A8B1 @default.
- Q79103069 P2093 Q79103069-6E91B1F9-08AB-4B67-BE9D-00100D34EAD6 @default.
- Q79103069 P2093 Q79103069-6F2A3496-0D81-49F8-A4C0-4FE438983A44 @default.
- Q79103069 P2093 Q79103069-831242DD-716D-43BB-ADC9-2568CA5A2C83 @default.
- Q79103069 P2093 Q79103069-C8E2D797-CAE7-4DA6-94F3-C0C12CDE2818 @default.
- Q79103069 P2093 Q79103069-C937964C-6C3D-47B8-A29D-1D9C36800472 @default.
- Q79103069 P2093 Q79103069-CC5BD8F1-377E-409C-A1E2-C849E925D0D1 @default.
- Q79103069 P2093 Q79103069-CD2A687E-B79E-47A0-9918-9180F4936C62 @default.
- Q79103069 P2860 Q79103069-213103B8-C9A9-4E00-A7DB-49F9A551CA5D @default.
- Q79103069 P2860 Q79103069-40D4D979-22CE-4DF2-80E3-AA9635449303 @default.
- Q79103069 P2860 Q79103069-48CDCFA4-7814-437E-8F21-1B18E236CA31 @default.
- Q79103069 P2860 Q79103069-69F4345D-3B47-4D5A-9636-9DC4B75556C3 @default.
- Q79103069 P2860 Q79103069-6BEBCDC9-A4F3-45A4-9B3C-96C859E18497 @default.
- Q79103069 P2860 Q79103069-7BD1B07C-B371-45B4-97AA-F9DA28CBDBFC @default.
- Q79103069 P2860 Q79103069-C23A4635-5C4E-4EEF-AF5F-AD27BD833833 @default.
- Q79103069 P2860 Q79103069-E11AEFAF-7234-4143-8669-1DA0EB83A07A @default.
- Q79103069 P2888 Q79103069-AD26DC41-4899-488C-BAD3-0441F3630087 @default.
- Q79103069 P304 Q79103069-761464F8-96FF-4FE2-89FE-C1C82604895D @default.
- Q79103069 P31 Q79103069-A1F2BCA9-8EB4-4A97-9EBE-8D287674760F @default.
- Q79103069 P356 Q79103069-25C6D550-5862-46F0-BC72-FD6AFCB287C9 @default.
- Q79103069 P433 Q79103069-AE752693-9879-487D-9732-4788828B77BA @default.
- Q79103069 P478 Q79103069-75B1F3E0-8CEF-4623-A170-89C6BF1E0073 @default.
- Q79103069 P50 Q79103069-BCF7302A-3628-4574-838F-EC0DEAF06481 @default.
- Q79103069 P577 Q79103069-9D262AF8-BFAD-4B9F-9907-7AD3B33ABAC3 @default.
- Q79103069 P6179 Q79103069-DA26B649-56EA-4A3B-89E9-D560E6B37DD7 @default.
- Q79103069 P698 Q79103069-60493777-9953-47B7-912E-1542CA3D197F @default.
- Q79103069 P8608 Q79103069-D7E71EC7-8930-42D4-A300-D7BC59A09646 @default.
- Q79103069 P921 Q79103069-48F107CD-AB57-43AD-B8A8-FEB9F37D073E @default.
- Q79103069 P356 SJ.BMT.1704241 @default.
- Q79103069 P698 14520434 @default.
- Q79103069 P1433 Q4941523 @default.
- Q79103069 P1476 "Level of minimal residual disease prior to haematopoietic stem cell transplantation predicts prognosis in paediatric patients with acute lymphoblastic leukaemia: a report of the Pre-BMT MRD Study Group" @default.
- Q79103069 P2093 "Bader P" @default.
- Q79103069 P2093 "Goulden N" @default.
- Q79103069 P2093 "Hancock J" @default.
- Q79103069 P2093 "Klingebiel T" @default.
- Q79103069 P2093 "Krejci O" @default.
- Q79103069 P2093 "Kreyenberg H" @default.
- Q79103069 P2093 "Lankester A" @default.
- Q79103069 P2093 "Révész T" @default.
- Q79103069 P2093 "Schilham MW" @default.
- Q79103069 P2093 "van der Velden VH" @default.
- Q79103069 P2860 Q38455373 @default.
- Q79103069 P2860 Q53349829 @default.
- Q79103069 P2860 Q73283122 @default.
- Q79103069 P2860 Q74171275 @default.
- Q79103069 P2860 Q74399712 @default.
- Q79103069 P2860 Q74408930 @default.
- Q79103069 P2860 Q74459338 @default.
- Q79103069 P2860 Q78035217 @default.
- Q79103069 P2888 sj.bmt.1704241 @default.
- Q79103069 P304 "849-851" @default.
- Q79103069 P31 Q13442814 @default.
- Q79103069 P356 "10.1038/SJ.BMT.1704241" @default.
- Q79103069 P433 "8" @default.
- Q79103069 P478 "32" @default.
- Q79103069 P50 Q60655923 @default.
- Q79103069 P577 "2003-10-01T00:00:00Z" @default.
- Q79103069 P6179 "1043684030" @default.
- Q79103069 P698 "14520434" @default.
- Q79103069 P8608 "release_4qay554jy5etph5u3iwshor4f4" @default.
- Q79103069 P921 Q65592366 @default.